Moreover, we demonstrated that the combination of this PDC with an anti-PD-1 antibody had a potent synergistic effect, enhancing the activation of CD8+ T cells within the tumor microenvironment, diminishing the expression of immunosuppressive factors, and upregulating the expression of immunostimulatory factors, as shown in Figure 5 [152]. Here, PDCD1 is linked to neoplasm.